Cited by 326Diabetes Management and ResearchObesity, Physical Activity, DietDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Temporal patterns in overweight and obesity in Type 1 diabetes

Open access

Conway, B., Miller, R. G., Costacou, T., Fried, L., Kelsey, S., Evans, R. W., Orchard, T. J.·2010·Diabetic Medicine

DOI 10.1111/j.1464-5491.2010.02956.xPMC PMC3129711

Open this paper in CoChat — free account

Abstract

Diabet. Med. 27, 398–404 (2010) Aims Time trends in overweight and obesity in the general population have been well documented; however, temporal patterns in Type 1 diabetes (T1DM) have not been thoroughly investigated. We therefore assessed temporal patterns in overweight and obesity and predictors of weight change in 589 individuals from the Pittsburgh Epidemiology of Diabetes Complications Study, a cohort of childhood‐onset T1DM. Methods Participants were first seen in 1986–1988, when mean age and diabetes duration were 29 and 20 years, respectively, and biennially thereafter for 18 years. Overweight was defined as 25.0 ≤ body mass index (BMI) < 30.0 kg/m 2. Obesity was defined as BMI ≥ 30.0 kg/m 2. Results At baseline, the prevalence of overweight and obesity were 28.6% and 3.4%, respectively. After 18 years’ follow‐up, the prevalence of overweight increased by 47% while the prevalence of obesity increased sevenfold. Seven per cent were on intensive insulin therapy (≥ 3 insulin injections per day or on insulin pump) at baseline; by 2004–2007, this was 82%. Predictors of weight change were a higher baseline HbA 1c, symptomatic autonomic neuropathy (inversely), overt nephropathy (inversely), and going onto intensive insulin therapy during follow‐up. Conclusions These data demonstrate dramatic weight gain in T1DM and underscore the complexity of weight change in this disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1111/j.1464-5491.2010.02956.x

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
(1998) · The Lancet · doi:10.1016/s0140-6736(98)07019-6 · Cited by 20,023
Prevalence of Overweight and Obesity in the United States, 1999-2004
Ogden, C. L., Carroll, M. D., Curtin, L. R., McDowell, M. A., Tabak, C. J., & Flegal, K. M. (2006) · JAMA · doi:10.1001/jama.295.13.1549 · Cited by 8,720
Prevalence and trends in obesity among US adults, 1999–2000
Flegal, K. M. (2002) · JAMA · doi:10.1001/jama.288.14.1723 · Cited by 6,190
Dietary Advanced Glycation End Products and Their Potential Role in Cardiometabolic Disease in Children
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,023
The Obesity Epidemic in the United States Gender, Age, Socioeconomic, Racial/Ethnic, and Geographic Characteristics: A Systematic Review and Meta-Regression Analysis
Wang, Y., & Beydoun, M. A. (2007) · Epidemiologic Reviews · doi:10.1093/epirev/mxm007 · Cited by 2,854
The Spread of the Obesity Epidemic in the United States, 1991-1998
Mokdad, A. H. (1999) · JAMA · doi:10.1001/jama.282.16.1519 · Cited by 2,384
Applied Regression Analysis and Other Multivariable Methods.
Bhattacharyya, H. T., Kleinbaum, D. G., & Kupper, L. L. (1979) · Journal of the American Statistical Association · doi:10.2307/2287012 · Cited by 1,767
The Epidemiology of Obesity
Ogden, C. L., Yanovski, S. Z., Carroll, M. D., & Flegal, K. M. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.052 · Cited by 1,561
Does physical activity prevent weight gain – a systematic review
Fogelholm, M., & Kukkonen‐Harjula, K. (2000) · Obesity Reviews · doi:10.1046/j.1467-789x.2000.00016.x · Cited by 598
Effect of Excessive Weight Gain With Intensive Therapy of Type 1 Diabetes on Lipid Levels and Blood Pressure: Results From the DCCT
Purnell, J. Q., Hokanson, J. E., Marcovina, S. M., Steffes, M. W., Cleary, P. A., & Brunzell, J. D. (1998) · JAMA · doi:10.1001/jama.280.2.140 · Cited by 469

Show all 24 references

Sorted by citations

American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity
Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914
Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report
Evert, A. B., Dennison, M., Gardner, C. D., Garvey, W. T., Lau, K. H. K., MacLeod, J., Mitri, J., Pereira, R. F., Rawlings, K., Robinson, S., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0014 · Cited by 1,496
Diabetes and hypertension: the bad companions
Ferrannini, E., & Cushman, W. C. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60987-8 · Cited by 705
Type 1 Diabetes Mellitus and Cardiovascular Disease
de Ferranti, S. D., de Boer, I. H., Fonseca, V. A., Fox, C. S., Golden, S. H., Lavie, C. J., Magge, S. N., Marx, N., McGuire, D. K., Orchard, T. J., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000034 · Cited by 516
Self-citation
Type 1 Diabetes Mellitus and Cardiovascular Disease: A Scientific Statement From the American Heart Association and American Diabetes Association
de Ferranti, S. D., de Boer, I. H., Fonseca, V. A., Fox, C. S., Golden, S. H., Lavie, C. J., Magge, S. N., Marx, N., McGuire, D. K., Orchard, T. J., et al. (2014) · Diabetes Care · doi:10.2337/dc14-1720 · Cited by 444
Self-citation
Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus
Fullerton, B., Jeitler, K., Seitz, M., Horvath, K., Berghold, A., & Siebenhofer, A. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009122.pub2 · Cited by 299
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial
Dandona, P., Mathieu, C., Phillip, M., Hansen, L., Griffen, S. C., Tschöpe, D., THOREN, F. A., Xu, J. L., Langkilde, A. M., Proietto, J., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30308-x · Cited by 299
Reversal of Type 1 Diabetes in Mice by Brown Adipose Tissue Transplant
Gunawardana, S. C., & Piston, D. W. (2012) · Diabetes · doi:10.2337/db11-0510 · Cited by 290
Obesity in Type 1 Diabetes: Pathophysiology, Clinical Impact, and Mechanisms
Corbin, K. D., Driscoll, K. A., Pratley, R. E., Smith, S. R., Maahs, D. M., Mayer-Davis, E. J., & Advancing Care for Type 1 Diabetes and Obesity Network (ACT1ON) (2018) · Endocrine Reviews · doi:10.1210/er.2017-00191 · Cited by 262
Efficacy and safety of liraglutide added to capped insulin treatment in subjects with type 1 diabetes: The adjunct two randomized trial
Ahrén, B., Hirsch, I. B., Pieber, T. R., Mathieu, C., Gómez-Peralta, F., Hansen, T. K., Philotheou, A., Birch, S., Christiansen, E., Jensen, T. J., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0690 · Cited by 262
Type 1 diabetes
Quattrin, T., Mastrandrea, L. D., & Walker, L. S. K. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00223-4 · Cited by 292
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: the DEPICT-1 52-week study
Dandona, P., Mathieu, C., Phillip, M., Hansen, L., Tschöpe, D., Thorén, F., Xu, J., Langkilde, A. M., DEPICT-1 Investigators, Proietto, J., et al. (2018) · Diabetes Care · doi:10.2337/dc18-1087 · Cited by 243
Type 1 diabetes, metabolic syndrome and cardiovascular risk
Chillarón, J. J., Flores Le-Roux, J. A., Benaiges, D., & Pedro-Botet, J. (2014) · Metabolism · doi:10.1016/j.metabol.2013.10.002 · Cited by 195
Obesity in people living with type 1 diabetes
der Schueren, B. V., Ellis, D., Faradji, R. N., Al‐Ozairi, E., Rosen, J., & Mathieu, C. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00246-1 · Cited by 201
Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial
Dejgaard, T. F., Frandsen, C. S., Hansen, T. S., Almdal, T., Urhammer, S. A., Pedersen‐Bjergaard, U., Jensen, T. J., Jensen, A. K., Holst, J. J., Tarnow, L., et al. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00436-2 · Cited by 183
Weight management in patients with type 1 diabetes and obesity
Mottalib, A., Kasetty, M., Mar, J. Y., Elseaidy, T., Ashrafzadeh, S., & Hamdy, O. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0918-8 · Cited by 149
Puberty as an accelerator for diabetes complications
Cho, Y. H., Craig, M. E., & Donaghue, K. C. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12112 · Cited by 145
Obesity and glycemic control in patients with diabetes mellitus: Analysis of physician electronic health records in the US from 2009–2011
Bae, J. P., Lage, M. J., Mo, D., Nelson, D. R., & Hoogwerf, B. J. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.11.016 · Cited by 137
Predictors of increasing BMI during the course of diabetes in children and adolescents with type 1 diabetes: data from the German/Austrian DPV multicentre survey
Fröhlich-Reiterer, E. E., Rosenbauer, J., Pozza, S. B., Hofer, S. E., Schober, E., Holl, R. W., & on behalf of the DPV-Wiss Study Group and the German BMBF Competence Networks Diabetes mellitus and Obesity (2014) · Archives of Disease in Childhood · doi:10.1136/archdischild-2013-304237 · Cited by 128
Double diabetes: a distinct high-risk group?
Kietsiriroje, N., Pearson, S., Campbell, M., Ariëns, R. A. S., & Ajjan, R. A. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13848 · Cited by 123
Lipids and lipid management in diabetes
Jaiswal, M., Schinske, A., & Pop‐Busui, R. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.12.001 · Cited by 118
The emergence of obesity in type 1 diabetes
Kueh, M. T. W., Chew, N., Al‐Ozairi, E., & le Roux, C. W. (2023) · International Journal of Obesity · doi:10.1038/s41366-023-01429-8 · Cited by 135
Effect of Aerobic and Resistance Exercise on Glycemic Control in Adults With Type 1 Diabetes
Reddy, R. K. K., Wittenberg, A., Castle, J. R., Youssef, J. E., Winters‐Stone, K. M., Gillingham, M. B., & Jacobs, P. G. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2018.08.193 · Cited by 121
EQ-5D Scores for Diabetes-Related Comorbidities
Sullivan, P. W., & Ghushchyan, V. H. (2016) · Value in Health · doi:10.1016/j.jval.2016.05.018 · Cited by 106
BMI, Mortality, and Cardiovascular Outcomes in Type 1 Diabetes: Findings Against an Obesity Paradox
Edqvist, J., Rawshani, A., Adiels, M., Bjorck, L. M., Lind, M., Svensson, A., Gudbjörnsdottir, S., Sattar, N. A., & Rosengren, A. (2019) · Diabetes Care · doi:10.2337/dc18-1446 · Cited by 102
Diabesity and antidiabetic drugs
Pappachan, J. M., Fernandez, C. J., & Chacko, E. C. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.10.004 · Cited by 105
A Review of Insulin Resistance in Type 1 Diabetes: Is There a Place for Adjunctive Metformin?
Priya, G., & Kalra, S. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0333-9 · Cited by 98
Non-insulin drugs to treat hyperglycaemia in type 1 diabetes mellitus
Frandsen, C. S., Dejgaard, T. F., & Madsbad, S. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)00039-5 · Cited by 98
Treatment of Obesity in Patients With Diabetes
Bramante, C. T., Lee, C. J., & Gudzune, K. A. (2017) · Diabetes Spectrum · doi:10.2337/ds17-0030 · Cited by 103
Obesity in Patients with Type 1 Diabetes: Links, Risks and Management Challenges
Vilarrasa, N., José, P. S., Rubio, M. Á., & Lecube, A. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s223618 · Cited by 98
Overweight and Obesity in Youth With Type 1 Diabetes
Minges, K. E., Whittemore, R., & Grey, M. J. (2013) · Annual Review of Nursing Research · doi:10.1891/0739-6686.31.47 · Cited by 87
TG/HDL-C ratio and visceral adiposity index may be useful in assessment of insulin resistance in adults with type 1 diabetes in clinical practice
Uruska, A. A., Zozulińska‐Ziółkiewicz, D., Niedźwiecki, P., Pietrzak, M., & Wierusz‐Wysocka, B. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.01.005 · Cited by 85
Efficacy and Safety of Resveratrol in Type 1 Diabetes Patients: A Two-Month Preliminary Exploratory Trial
Movahed, A., Raj, P., Nabipour, I., Mahmoodi, M., Ostovar, A., Kalantarhormozi, M., & Netticadan, T. (2020) · Nutrients · doi:10.3390/nu12010161 · Cited by 83
Insulin Resistance in Type 1 Diabetes Mellitus and Its Association with Patient’s Micro- and Macrovascular Complications, Sex Hormones, and Other Clinical Data
Šimonienė, D., Platūkienė, A., Prakapienė, E., Radzevičienė, L., & Veličkienė, D. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-00729-5 · Cited by 83
Lifestyle and Cardiometabolic Risk in Adults with Type 1 Diabetes: A Review
Leroux, C., Brazeau, A., Gingras, V., Desjardins, K., Strychar, I. M., & RABASA-LHORET, R. P. R. (2014) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.08.268 · Cited by 81
Cardiovascular risk in double diabetes mellitus—when two worlds collide
Cleland, S. J. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.47 · Cited by 81
Obesity is associated with retinopathy and macrovascular disease in type 1 diabetes
Price, S. A., Gorelik, A., Fourlanos, S., Colman, P. G., & Wentworth, J. M. (2014) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2013.03.007 · Cited by 77
Genetic Evidence for a Causal Role of Obesity in Diabetic Kidney Disease
Todd, J. N., Dahlström, E. H., Salem, R. M., Sandholm, N., Forsblom, C. M., the FinnDiane Study Group, McKnight, A. J., Maxwell, A. P., Brennan, E. P., Sadlier, D. M., et al. (2015) · Diabetes · doi:10.2337/db15-0254 · Cited by 75
Liraglutide reduces hyperglycaemia and body weight in overweight, dysregulated insulin‐pump‐treated patients with type 1 diabetes: The Lira Pump trial—a randomized, double‐blinded, placebo‐controlled trial
Dejgaard, T. F., Schmidt, S., Frandsen, C. S., Vistisen, D., Madsbad, S., Andersen, H. U., & Nørgaard, K. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13911 · Cited by 75
Prevalence of overweight, obesity and metabolic syndrome components in children, adolescents and young adults with type 1 diabetes mellitus
Pinhas‐Hamiel, O., Levek, N., Kaidar, K., Boyko, V., Tisch, E., Mazor‐Aronovitch, K., Graph‐Barel, C., Landau, Z., Lerner‐Geva, L., & Ben‐David, R. F. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2565 · Cited by 73
Dyslipidemia in young patients with type 1 diabetes mellitus
Homma, T. K., Endo, C. M., Saruhashi, T., Mori, A. P. I., Noronha, R. C. R., Monte, O., & Calliari, L. E. (2015) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000040 · Cited by 72
Metabolic Diversity of Progressive Kidney Disease in 325 Patients with Type 1 Diabetes (the FinnDiane Study)
Mäkinen, V., Tynkkynen, T., Soininen, P., Peltola, T., Kangas, A. J., Forsblom, C. M., Thorn, L. M., Kaski, K. K., Laatikainen, R., Ala‐Korpela, M., et al. (2011) · Journal of Proteome Research · doi:10.1021/pr201036j · Cited by 71
Metabolism amelioration of Dendrobium officinale polysaccharide on type II diabetic rats
Chen, H., Nie, Q., Hu, J., Huang, X., Huang, W., & Nie, S. (2019) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2019.105582 · Cited by 70
The Causes of Insulin Resistance in Type 1 Diabetes Mellitus: Is There a Place for Quaternary Prevention?
Wołosowicz, M., Łukaszuk, B., & Chabowski, A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17228651 · Cited by 69
A decade of temporal trends in overweight/obesity in youth with type 1 diabetes after the Diabetes Control and Complications Trial
Baskaran, C., Volkening, L. K., Diaz, M. M., & Laffel, L. M. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12166 · Cited by 66
Biopsychosocial Aspects of Weight Management in Type 1 Diabetes: a Review and Next Steps
on behalf of the Advancing Care for Type 1 Diabetes and Obesity Network (ACT1ON), Driscoll, K. A., Corbin, K. D., Maahs, D. M., Pratley, R. E., Bishop, F. K., Kahkoska, A. R., Hood, K. K., & Mayer‐Davis, E. J. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0892-1 · Cited by 67
Cross-sectional and longitudinal relationships of body mass index with glycemic control in children and adolescents with type 1 diabetes mellitus
Nansel, T. R., Lipsky, L. M., & Iannotti, R. J. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.12.025 · Cited by 63
Gender and age-dependent effect of type 1 diabetes on obesity and altered body composition in young adults
Szadkowska, A., Madej, A., Ziółkowska, K., Szymańska, M., Jeziorny, K., Mianowska, B., & Pietrzak, I. (2015) · Annals of Agricultural and Environmental Medicine · doi:10.5604/12321966.1141381 · Cited by 62
Carbohydrate Restriction in Type 1 Diabetes: A Realistic Therapy for Improved Glycaemic Control and Athletic Performance?
Scott, S. N., Anderson, L., Morton, J. P., Wagenmakers, A. J. M., & Riddell, M. C. (2019) · Nutrients · doi:10.3390/nu11051022 · Cited by 65
Real-world Evidence of Efficacy and Safety of SGLT2 Inhibitors as Adjunctive Therapy in Adults With Type 1 Diabetes: A European Two-Center Experience
Palanca, A., van Nes, F., Pardo, F., Ampudia‐Blasco, F. J., & Mathieu, C. (2022) · Diabetes Care · doi:10.2337/dc21-1584 · Cited by 60
Abdominal adiposity and cardiovascular risk factors in adolescents with type 1 diabetes
Valerio, G., Iafusco, D., Zucchini, S., & Maffeis, C. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.01.022 · Cited by 58
Serum omentin-1 levels in type 2 diabetic obese women in relation to glycemic control, insulin resistance and metabolic parameters
Elsaid, N. H., Sadik, N. A., Ramadan, N., Fayez, S. E., & Mohamed, N. (2018) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2018.05.003 · Cited by 63
Glycaemic control and weight 7 years after Dose Adjustment For Normal Eating (DAFNE) structured education in Type 1 diabetes
Gunn, D., & Mansell, P. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03525.x · Cited by 56
Cardiovascular disease and type 1 diabetes: prevalence, prediction and management in an ageing population
Lee, S. I., Patel, M., Jones, C. M., & Narendran, P. (2015) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622315598502 · Cited by 58
The Emerging Role Of Adjunctive Noninsulin Antihyperglycemic Therapy In The Management Of Type 1 Diabetes
Bode, B. W., & Garg, S. K. (2015) · Endocrine Practice · doi:10.4158/ep15869.ra · Cited by 55
Effect of Excess Gestational Weight Gain on Pregnancy Outcomes in Women With Type 1 Diabetes
Scifres, C., Feghali, M. N., Althouse, A. D., Caritis, S. N., & Catov, J. M. (2014) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000000271 · Cited by 54
Disordered Eating Behaviors Are Associated with Poorer Diet Quality in Adolescents with Type 1 Diabetes
Tse, J., Nansel, T. R., Haynie, D. L., Mehta, S. N., & Laffel, L. M. (2012) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2012.06.359 · Cited by 55
Obesity and kidney disease in type 1 and 2 diabetes: an analysis of the National Diabetes Audit
Hill, C. J., Cardwell, C. R., Maxwell, A. P., Young, R. J., Matthews, B. B., O'Donoghue, D. J., & Fogarty, D. G. (2013) · QJM · doi:10.1093/qjmed/hct123 · Cited by 54
Diet, physical, and biochemical characteristics of children and adolescents with type 1 diabetes: relationship between dietary fat and glucose control
Maffeis, C., Morandi, A., Ventura, E. E., Sabbion, A., Contreas, G., Tomasselli, F., Tommasi, M., Fasan, I., Costantini, S., & Pinelli, L. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00781.x · Cited by 54
GLP-1 Agonists in Type 1 Diabetes Mellitus
Janzen, K. M., Steuber, T. D., & Nisly, S. A. (2016) · Annals of Pharmacotherapy · doi:10.1177/1060028016651279 · Cited by 57
Comparison of a Mediterranean to a low-fat diet intervention in adults with type 1 diabetes and metabolic syndrome: A 6–month randomized trial
Fortin, A., RABASA-LHORET, R. P. R., Lemieux, S., Labonté, M., & Gingras, V. (2018) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2018.08.005 · Cited by 52
Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus
Fullerton, B., Berghold, A., Jeitler, K., & Siebenhofer, A. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009122 · Cited by 51
Subjective sleep disturbances and glycemic control in adults with long-standing type 1 diabetes: The Pittsburgh’s Epidemiology of Diabetes Complications study
Denic-Roberts, H., Costacou, T., & Orchard, T. J. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.06.013 · Cited by 51
Self-citation
mTOR: A double-edged sword for diabetes
Tuo, Y., & Xiang, M. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0317-095rr · Cited by 50
Treatment Goals in Diabetes
Melmer, A., & Laimer, M. W. (2016) · Endocrine development · doi:10.1159/000439364 · Cited by 53
Body Mass Index, Diabetes, Hypertension, and Short-Term Mortality: A Population-Based Observational Study, 2000-2006
Jerant, A. F., & Franks, P. J. (2012) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2012.04.110289 · Cited by 48
Safety and efficacy of insulin therapy delivered via a 4mm pen needle in obese patients with diabetes
Bergenstal, R. M., Strock, E. S., Peremislov, D., Gibney, M. A., Parvu, V., & Hirsch, L. J. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.12.014 · Cited by 54
Omentin-1 plasma levels and cholesterol metabolism in obese patients with diabetes mellitus type 1: impact of weight reduction
Lesná, J., Tichá, A., Hyšpler, R., Musil, F., Blaha, V., Sobotka, L., Zadák, Z., & Šmahelová, A. (2015) · Nutrition and Diabetes · doi:10.1038/nutd.2015.33 · Cited by 47
Type 1 Diabetes Treatment beyond Insulin: Role of GLP-1 Analogs
Harrison, L., Mora, P. F., Clark, G. O., & Lingvay, I. (2013) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e318279b7d6 · Cited by 46
Reducing Type 1 Diabetes Mortality: Role for Adjunctive Therapies?
Snaith, J. R., Holmes-Walker, D. J., & Greenfield, J. R. (2020) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2019.11.007 · Cited by 45
Nutrition and Obesity in the Pathogenesis of Youth-Onset Type 1 Diabetes and Its Complications
March, C. A., BECKER, D. J., & Libman, I. M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.622901 · Cited by 50
Counter‐regulatory hormone responses to hypoglycaemia in people with type 1 diabetes after 4 weeks of treatment with liraglutide adjunct to insulin: a randomized, placebo‐controlled, double‐blind, crossover trial
Pieber, T. R., Deller, S., Korsatko, S., Jensen, L., Christiansen, E., Madsen, J. C., & Heller, S. R. (2015) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12473 · Cited by 46
Weight Management in Diabetes
Wharton, S., Sharma, A. M., & Lau, D. C. W. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.025 · Cited by 44
Should metabolic surgery be offered in morbidly obese patients with type I diabetes?
Robert, M., Belanger, P., Hould, F., Marceau, S., Tchernof, A., & Biertho, L. D. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.12.016 · Cited by 43
Sodium‐glucose co‐transporter inhibitors as adjunctive treatment to insulin in type 1 diabetes: A review of randomized controlled trials
BOEDER, S. C., & Edelman, S. V. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13749 · Cited by 44
The Role of Physical Exercise in Obesity and Diabetes
Melmer, A., Kempf, P., & Laimer, M. W. (2018) · Praxis · doi:10.1024/1661-8157/a003065 · Cited by 42
Body Mass Index and Mortality in Individuals With Type 1 Diabetes
Dahlström, E. H., Sandholm, N., Forsblom, C. M., Thorn, L. M., Sigfrids, F. J., Harjutsalo, V., & Groop, P. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00042 · Cited by 43
Predictors of cardiovascular risk among patients with type 1 diabetes: A critical analysis of the metabolic syndrome and its components
Gingras, V., Leroux, C., Fortin, A., Legault, L., & RABASA-LHORET, R. P. R. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2016.10.007 · Cited by 42
The Humanistic Burden of Type 1 Diabetes Mellitus in Europe: Examining Health Outcomes and the Role of Complications
Rydén, A., Sörstadius, E., Bergenheim, K., Romanovschi, A., THOREN, F. A., Witt, E. A., & Sternhufvud, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164977 · Cited by 41
Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes
Ranjan, A., Schmidt, S., Madsbad, S., Holst, J. J., & Nørgaard, K. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12627 · Cited by 39
Metformin beyond type 2 diabetes: Emerging and potential new indications
Petrie, J. R. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15756 · Cited by 48
Metformin in adults with type 1 diabetes: D esign and methods of REducing with MetfOrmin V ascular A dverse L esions ( REMOVAL ): A n international multicentre trial
Petrie, J. R., Chaturvedi, N., Ford, I., HRAMIAK, I. M., Hughes, A. D., Jenkins, A. J., Klein, B. E. K., Klein, R., Ooi, T. C., Rossing, P. R., et al. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12840 · Cited by 39
Highlighting the Role of Obesity and Insulin Resistance in Type 1 Diabetes and Its Associated Cardiometabolic Complications
Karamanakos, G., Kokkinos, A. D., Dalamaga, Μ., & Liatis, S. (2022) · Current Obesity Reports · doi:10.1007/s13679-022-00477-x · Cited by 44
Beyond glycaemic control: A cross‐over, double‐blinded, 24‐week intervention with liraglutide in type 1 diabetes
Dubé, M., D'Amours, M., & Weisnagel, S. J. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13063 · Cited by 38
A Systematic Review and Meta-Analysis of Outcomes for Type 1 Diabetes after Bariatric Surgery
Chow, A., Switzer, N. J., Dang, J. T., Shi, X., de Gara, C., Birch, D. W., Gill, R. S., & Karmali, S. (2016) · Journal of Obesity · doi:10.1155/2016/6170719 · Cited by 37
Burden of cardiovascular risk factors and disease among patients with type 1 diabetes: results of the Australian National Diabetes Audit (ANDA)
Pease, A., Earnest, A., Ranasinha, S., Nanayakkara, N., Liew, D., Wischer, N., Andrikopoulos, S., & Zoungas, S. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0726-8 · Cited by 40
The safety and efficacy of weight loss via intermittent fasting or standard daily energy restriction in adults with type 1 diabetes and overweight or obesity: A pilot study
Overland, J., Toth, K., Gibson, A. A., Sainsbury, A., Franklin, J., Gauld, A., & Wong, J. (2018) · Obesity Medicine · doi:10.1016/j.obmed.2018.11.001 · Cited by 34
The association between overweight/obesity and double diabetes in adults with type 1 diabetes; a cross-sectional study
Cantley, N. W. P., Lonnen, K., Kyrou, I., Tahrani, A. A., & Kahal, H. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00851-1 · Cited by 34
Robotic pancreas transplantation in a type 1 diabetic patient with morbid obesity
Yeh, C. C., Spaggiari, M., Tzvetanov, I. G., & Oberholzer, J. (2017) · Medicine · doi:10.1097/md.0000000000005847 · Cited by 31
Glycemic control and variability in association with body mass index and body composition over 18months in youth with type 1 diabetes
Lipsky, L. M., Gee, B. T., Liu, A., & Nansel, T. R. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.07.028 · Cited by 31
Bariatric Surgery for Severe Obesity in Two Adolescents With Type 1 Diabetes
Chuang, J., Zeller, M. H., Inge, T. H., & Crimmins, N. A. (2013) · PEDIATRICS · doi:10.1542/peds.2012-3640 · Cited by 30
Utility of the waist-to-height ratio, waist circumference and body mass index in the screening of metabolic syndrome in adult patients with type 1 diabetes mellitus
Ferreira‐Hermosillo, A., Ramírez‐Rentería, C., Mendoza‐Zubieta, V., & Molina-Ayala, M. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-32 · Cited by 30
Long-term body weight trajectories and metabolic control in type 1 diabetes patients on insulin pump or multiple daily injections: A 10-year retrospective controlled study
Alderisio, A., Bozzetto, L., Franco, L., Riccardi, G., Rivellese, A. A., & Annuzzi, G. (2019) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.06.008 · Cited by 30
Benefit/risk profile of dapagliflozin 5 mg in the DEPICT ‐1 and ‐2 trials in individuals with type 1 diabetes and body mass index ≥27 kg/m 2
Mathieu, C., Dandona, P., Birkenfeld, A. L., Hansen, T. K., Iqbal, N., Xu, J. L., Repetto, E., Scheerer, M. F., THOREN, F. A., & Phillip, M. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14144 · Cited by 31
Can type 1 diabetes be an unexpected complication of obesity?
Oboza, P., Ogarek, N., Olszanecka‐Glinianowicz, M., & Kocełak, P. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1121303 · Cited by 31
Inflammatory Cytokine Profile Associated with Metabolic Syndrome in Adult Patients with Type 1 Diabetes
Ferreira‐Hermosillo, A., Molina-Ayala, M., Ramírez‐Rentería, C., Vargas‐Ortega, G., González‐Virla, B., Isibasi, A., Archundia-Riveros, I., & Mendoza, V. (2015) · Journal of Diabetes Research · doi:10.1155/2015/972073 · Cited by 29
Body mass index standard deviation score and obesity in children with type 1 diabetes in the Nordic countries. HbA1c and other predictors of increasing BMISDS
Birkebæk, N., Kahlert, J. A., Bjarnason, R. G., Drivvoll, A., Johansen, A., Konrádsdóttir, E., Pundziūtė-Lyckå, A., Samuelsson, U., Skrivarhaug, T., Svensson, J., et al. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12693 · Cited by 31
Liraglutide changes body composition and lowers added sugar intake in overweight persons with insulin pump-treated type 1 diabetes
Schmidt, S., Frandsen, C. S., Dejgaard, T. F., Vistisen, D., Halldórsson, T., Olsen, S. F., Jensen, J. B., Madsbad, S., Andersen, H. U., & Nørgaard, K. (2022) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14567 · Cited by 29
Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT‐5): 52‐week results from a randomized, open‐label, phase III clinical trial
Araki, E., Watada, H., Uchigata, Y., Tomonaga, O., Fujii, H., Ohashi, H., Okabe, T., Asano, M., THOREN, F. A., Kim, H., et al. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13922 · Cited by 28
Emerging Aspects of the Body Composition, Bone Marrow Adipose Tissue and Skeletal Phenotypes in Type 1 Diabetes Mellitus
Carvalho, A. L., Massaro, B., Parreiras‐e‐Silva, L. T., Salmón, C. E. G., Fukada, S. Y., Nogueira‐Barbosa, M. H., Elías, J., Foss‐Freitas, M. C., Couri, C. E. B., Oliveira, M. C., et al. (2018) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2018.06.007 · Cited by 28

Authors: Conway, B., Miller, R. G., Costacou, T., Fried, L., Kelsey, S., Evans, R. W., & Orchard, T. J.
Affiliations: University of Pittsburgh (US)
VA Pittsburgh Healthcare System (US)
Corresponding author: Orchard, T. J.
ORCID: Conway, B.
Miller, R. G.
Costacou, T.
Orchard, T. J.
Venue: Diabetic Medicine
Publisher: Wiley
Published: 2010-04
Volume: 27
Issue: 4
Pages: 398-404
ISSN: 0742-3071 (ISSN-L)
1464-5491
DOI: 10.1111/j.1464-5491.2010.02956.x
PMC: PMC3129711
OpenAlex: W2163890335
Cited by: 326
References: 24
Citations by year: 2026: 11 · 2025: 19 · 2024: 24 · 2023: 20 · 2022: 25 · 2021: 24 · 2020: 22 · 2019: 24 · 2018: 33 · 2017: 25 · 2016: 26 · 2015: 19 · 2014: 17 · 2013: 16 · 2012: 12
FWCI: 8.93
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 6 d)
Locations: Diabetic Medicine (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: American Diabetes Association
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases (R37DK034818, R01DK034818, DK-34818)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: type 1 diabetes, childhood-onset diabetes, overweight, obesity, weight gain, temporal trends, intensive insulin therapy, HbA1c, autonomic neuropathy, diabetic nephropathy, Pittsburgh Epidemiology of Diabetes Complications Study
MeSH terms: Adolescent, Adult, Diabetes Mellitus, Type 1, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Insulin, Middle Aged, Obesity, Predictive Value of Tests, Prospective Studies, Risk Factors, Time Factors, Weight Gain, Body Mass Index, Prevalence, Overweight, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Temporal patterns in overweight and obesity in Type 1 diabetes

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks